Focus on ChromaID to Aid in Enhanced 3-D and Holographic Imaging for Certain Medical Procedures SEATTLE–(BUSINESS WIRE)–Dec. 7, 2016– Visualant, Inc. (OTCQB: VSUL) – a photonics technology development company providing chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, announced today that it has entered into a Joint Development Agreement with BIOMEDX Group, Inc., to develop its ChromaID technology as an exclusive analytical photonic tool for Aesthetics, Dermatology and Plastic Surgery. The BIOMEDX Group, Inc. is a technology company founded to develop and commercialize photo-realistic 3-D and holographic digital human modeling for the medical/healthcare industry. The Company is developing […]